Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_927_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
E  
C  R
H. Randolph Bailey, Michael J. Snyder, and Colin P. Bird


INTRODUCTION

Endometriosis is a disease characterized by the presence of endo­metrial glands and stroma outside the uterine cavity. A chronic inammatory reaction induces scar tissue and adhesion formation that may distort a woman’s pelvic anatomy and cause disabling pel­vic pain and intractable infertility. Although the cause of this disease is unknown, the most likely explanation involves the implantation of viable endometrial cells from retrograde menstruation through the fallopian tubes. Endometriosis has been estimated to aect up to 15% of all women of reproductive age. Twenty percent of women with endometriosis will have intestinal involvement, and the major­ity of these cases involve the rectosigmoid region. Colon and rectal surgeons most commonly become involved in the management of patients with intestinal endometriosis as a combined procedure with a gynecologist treating the other pelvic implants, or in the manage­ment of an endometrioma masquerading as a neoplastic or inam­matory lesion. 

PAIN

Pain, the most common symptom of endometriosis, aects up to 80% of patients who are subsequently diagnosed with the disease. Dys­menorrhea is the most common gynecologic symptom. Intestinal symptoms of patients with deep inltrating endometriosis are pel­vic pain upon defecation (which can be cyclical), dyspareunia, and rectal bleeding. In women undergoing laparoscopy for pelvic pain, endometriosis is discovered in 30% to 50% of cases. Although the total lesion volume oen equates to the degree of pain, some women with extensive endometriosis experience little or no pain. Symptoms appear to be related to the depth of penetration, the type of lesion, and its location. Implants involving the uterosacral ligaments and rectovaginal septum are most oen implicated in patients with pelvic pain. is pain is typically most intense just prior to the onset of men­struation. It is oen associated with back pain, dyschezia, and levator muscle spasm and is more severe with advanced stages of endome­triosis. e presence of dyspareunia is oen seen with xation of the pelvic organs, especially in the cul-de-sac of Douglas, the uterosacral ligaments, and the rectovaginal septum. 

INFERTILITY

e exact causal relationship between endometriosis and infertility is also unclear, but the correlation is well established. In women with known endometriosis, the infertility rate is 30% to 50%, and con­versely, in infertile women, the incidence of endometriosis is 25% to 50%. Fecundity in normal couples ranges from 0.15 to 0.20 per month and decreases with age, whereas women with endometriosis tend to have a lower monthly fecundity of about 0.02 to 0.1. ere
is little disagreement that moderate to severe disease with mechani-
cal distortion of the fallopian tubes, ovaries, and peritoneum can
potentiate infertility. Pelvic endometriosis and the resulting inam-
matory response can produce dense, brotic adhesions that may
signicantly interfere with both the oocyte release from the ovary
and the ability of the fallopian tube to pick up and transmit the
oocyte to the uterus. In moderate or severe endometriosis, the preg-
nancy rates aer surgical removal of the endometrial implants are
50% and 40%, respectively, compared with only 7% when expect-
ant management is practiced. Treatment of infertile patients with
mild endometriosis is more problematic. Infertile women with mild
endometriosis did not have any improvement in fertility with either
medical or surgical therapy compared with expectant management.
Other studies have demonstrated a lower pregnancy per cycle rate
in patients with mild endometriosis compared with those who are
free of the disease. 

DIAGNOSIS

Physical Examination
Mild cases of endometriosis may not be demonstrable on physi-
cal examination. e diagnosis may not be made unless the patient
undergoes laparoscopy. Bimanual and rectal examination may reveal
nodularity or induration in the utero-sacral ligaments or the cul-de-
sac of Douglas. Fixed tender retroversion of the uterus in a patient
without previous pelvic surgery raises suspicion for endometriosis.
Cyclical pelvic and abdominal pain or bleeding from any location
should be investigated for endometriosis. e inguinal canal, previ-
ous incisions, umbilicus, and lungs can all potentially harbor endo-
metrial implants. 
Endoscopy
Endoscopic evaluation of the large bowel is oen normal except
in severe disease with inltrating nodular endometrial implants.
Colonoscopy is most useful in excluding colon cancer from the dif-
ferential diagnosis, especially in older patients presenting with a rec-
tosigmoid mass while undergoing hormone replacement therapy.
Because the typical lesions in endometriosis begin as serosal nodules,
colonoscopic evaluation will generally demonstrate grossly normal
appearance of the mucosa. Occasionally, however, signicant luminal
narrowing may be identied, a result of inltration of the submucosa,
which produces nodularity and distortion of the overlying mucosa.
ese areas of distorted bowel may produce pain, suggesting the
diagnosis of endometriosis.
Rigid proctoscopy is very helpful in predicting the depth of rec-
tosigmoid involvement in patients with severe endometriosis of the
341
EndomEtriosis of thE Colon and rECtum342
cul-de-sac of Douglas. e mucosa is oen xed over areas of sub­mucosal or deep muscular involvement with tethering or puckering and loss of the normal mucosal mobility. In our experience, these mucosal ndings have correlated with signicant intestinal wall inva­sion by the endometrial implant and oen signal a need for intes­tinal resection. Our experience has demonstrated that this physical examination nding has a 70% positive predictive value for segmen­tal colonic resection. 
Imaging
Ultrasonography, barium enema, computerized tomography (CT), magnetic resonance imaging (MRI), and immunoscintigraphy have all been used to help diagnose endometriosis. Oen these tests are obtained during the evaluation and workup of chronic pelvic pain and/or bleeding from the reproductive tract or colon. Varying utility and sensitivity can be attributed to each modality, and their value is ultimately judged against the diagnostic gold standard, laparoscopy. Laparoscopy, however, can be inconclusive in assessing deep inltrat­ing disease and cul-de-sac involvement and in correctly predicting intestinal resection. As such, each imaging modality may have a role in future operative planning.
Transvaginal ultrasound provides specicity greater than 90% for ovarian endometriosis. In contrast, pelvic ultrasound is not very sen­sitive in detecting focal nonovarian endometrial implants. Although the procedure itself can be quite painful to the patient, if it can be tolerated, endorectal ultrasound will detect rectal wall invasion of endometrial implants in the cul-de-sac. Sensitivity and specicity of endorectal ultrasound for preoperative staging of rectal wall involve­ment by endometriosis have been reported to be as high as 97%, but its usefulness is limited by pain.
CT is the imaging technique used most frequently for the evalua­tion of abdominal and pelvic pain, mainly because of the availability of CT rather than its utility or sensitivity for this diagnosis. ere is no standard CT appearance for a mass caused by endometriosis to clearly dierentiate it from pelvic masses due to other causes. CT colonogra­phy may change this limitation because it is able to identify luminal alterations of the rectosigmoid colon and obliteration of the cul-de-sac, with sensitivity and specicity approaching 96% and 80%, respectively.
MRI continues to gain an increasing role in the diagnostic workup of endometriosis. Multiplanar capabilities and superior so tissue contrast are extremely useful in the detection of deeply inltrating endometriotic implants, even in the setting of an intense desmoplas­tic response that may result in complete obliteration of the posterior cul-de-sac and xed retroversion of the uterus. Colorectal involve­ment is strongly suspected when disappearance of the fat plane between the rectum and the vagina is noted, when the hypointense signal of the anterior bowel wall is lost on T2-weighted images, and when a contrast-enhanced mass involving the bowel wall is noted on T1-weighted images. e sensitivity and specicity of MRI for detecting and adequately evaluating colorectal endometriosis is approximately 78% and 98%, respectively. e ability of 1.5-T MRI to characterize the extent of cul-de-sac obliteration by endometriosis fell short, but the recent introduction of 3-T MRI oers a better space and contrast resolution, which may translate to better detection of cul-de-sac implants and associated bowel involvement. 

SURGICAL MANAGEMENT

e major goal of surgery in the management of endometriosis is to completely excise or ablate all endometrial implants. Secondary goals include the preservation of ovarian function and minimizing postoperative adhesion formation. When the rectum is involved, sev­eral approaches are to be considered, including shaving the disease o the rectal wall, a formal full-thickness disk excision of the anterior rectal wall, or a segmental excision of the rectum. Mobilization of the
rectum is an important part of treatment, even when the rectum is not directly invaded by endometriosis, to allow safe excision of the pelvic disease without injury to the rectum. e most eective treatment of pelvic pain still consists of surgical castration along with resection of the endometrial implants. However, many young patients have a strong desire to maintain their options for pregnancy. erefore, we approach these patients in concert with gynecologists experienced in treating pelvic endometriosis to completely remove all gross disease, restore normal anatomy, and optimize fertility.
e obliterative nature of endometriosis results in distortion of normal tissue planes, an environment that frequently is further com­plicated by adhesions from previous operations. Our goal is safe, meticulous removal of all endometriosis implants with minimal mor­bidity. As a result, we elect to perform most of these cases via an open laparotomy through a Pfannenstiel incision. All patients undergoing surgery for advanced endometriosis undergo a full mechanical bowel preparation. We place the patient in the low-lithotomy position to permit access to both the vagina and rectum for instrumentation. We frequently place ureteral stents, especially for reoperative cases. Intraoperative instrumentation of the vagina, proctoscopic evalua­tion of the rectum, and easy identication of the ureters all aid in both avoiding iatrogenic injury to these structures and identifying the endometriosis.
Within the cul-de-sac of Douglas, endometriosis implants are oen deep brotic nodules extending from the posterior vagina and anterior rectum to the uterosacral ligaments. ey frequently invade both the vagina and rectum. Although we routinely employ gonado­tropin-releasing hormone therapy preoperatively, a brotic reaction around the endometriosis tissue results in scarring in the bowel mus­cularis, leading not only to persistence of the patient’s symptoms but also mandating surgical resection for cure. It is vital to note that this “scar” can oen be quiescent endometriosis that grows when hor­monal suppression is stopped. Hormonal therapy is most eective in eradicating peritoneal disease and works poorly on ovarian and bowel implants. As a result, removal of these implants can require either resection of a portion of the rectal wall or segmental rectal resection.
Dissection of the lesion from the vagina isolates the lesion to the rectal wall and permits en bloc removal. Frequently no discern­ible plane exists between the endometrial nodules and the walls of the rectum or vagina. In women desiring eventual pregnancy, it is vital to completely remove the lesion. Care should be taken to avoid penetration of the vaginal wall and injury to the cervix; how­ever, should the mucosa be damaged, the key is recognizing that an injury has occurred and subsequently making the appropriate repair. Proceeding with the posterior and lateral dissection rst to adequately dene the lesion, in concert with blunt dissection of the rectovaginal plane below the area of involvement, can help clarify the distorted anatomy and avoid inadvertent entry into the bowel lumen or vagina.
Disk excision of the anterior rectal wall, by either laparoscopic or open technique, is performed for single lesions that are usually less than 2 cm in diameter (Fig. 68-1). When performing disk excision, the lesion is marked circumferentially with electrocautery followed by the placement of stay sutures. To minimize thermal spread, we use cutting current to perform a full-thickness excision. A rim of normal bowel is removed with the endometriosis to ensure complete removal of the lesion. Transverse closure by interrupted, absorbable suture (our preference is 2-0 or 3-0 Vicryl) is then used to close the defect.
Segmental resection of the rectosigmoid is reserved for larger lesions. High ligation of the sigmoid vessels is unnecessary, and the anastomosis may be either hand sewn or stapled. Our goal is to achieve margins with grossly normal bowel, and unless multiple lesions exist, an extensive colonic resection is not required. Although resection is amenable to laparoscopic techniques, we believe that poorly discern­able tissue planes, the intimate association of the rectum and vagina, the very rare occurrence of distal inltration of endometriosis down to the mid to lower rectum, and the tactile feedback aorded by an
FIGURE 68-1 Endometriosis disk excision from the anterior rectal
wall.
open technique permits a more complete resection, better long-term results, and minimal morbidity.
Removal of small intestine lesions requires sharp excision or
vaporization with electrocautery and/or the CO
laser. Both tech-
2
niques have the potential for iatrogenic injury to the intestinal or uri­nary tracts. Recognizing when a lesion is completely ablated is highly dependent on surgical technique and the expertise of the surgeon. Techniques that minimize injury to the surrounding tissue, such as a cutting current to outline lesions to be removed by electrocautery and high-power density settings with the CO
laser, are utilized. Aer
2
the lesion is removed, the bowel wall is carefully assessed. Because most of these supercial lesions can be removed without entering the mucosa, the defects usually can be reinforced with interrupted longi­tudinally placed Lembert stitches.
Results after Surgical Therapy
Because of the wide variability in the operative approach to endo­metriosis and the obvious need for postoperative laparoscopy to document asymptomatic failure of therapy, recurrence of endome­triosis aer surgical excision is dicult to determine. Studies sug­gest a rate of recurrent endometriosis ranging from 7% to 26%; no conclusive data indicate that a hysterectomy further reduces this percentage.
Evaluating the resolution of preoperative pelvic pain or infertility is an easier metric by which to judge surgical therapy. In the largest series of intestinal resections for advanced intestinal endometriosis, with a median follow-up of 5 years, it was found that 86% of patients had complete or near complete relief of their preoperative pelvic pain, as well as a 50% crude pregnancy rate, with minimal morbidity, no anastomotic leaks, and no documented instance of recurrent colorec­tal endometriosis. Currently, in patients with at least one ovary and a uterus, in-vitro fertilization can yield a much higher pregnancy rate than 50%.
In contrast, evaluation of full-thickness disk excision of bowel implants showed that approximately 40% were incomplete. A review of other large series reveals morbidity from segmental resection rang­ing up to 20%. Laparoscopic series of intestinal resections performed for extensive endometriosis have reported similar results, and more
COLON 343
recent series have demonstrated robotic feasibility. However, it is our group’s practice to perform these cases via open laparotomy through a Pfannenstiel incision. We believe the role of tactile feedback in assess­ing surgical margins and complete removal of deep pelvic lesions is crucial to removing all foci of disease and minimizing recurrence. In our experience, this practice has helped obviate the need for “ultra low” resections and intestinal diversion. It should be noted, however, that for severe disease, laparoscopic ablation, when possible, had similar crude pregnancy rates in comparison with laparotomy, and both techniques were clearly superior to medical management alone. 
Combined Medical and Surgical Therapy
In isolation, both medical and surgical therapy for endometriosis may not be successful in eradicating the disease. Medical therapy aects endometrial implants variably, and the recurrence rate aer cessa­tion of therapy is high. Surgery alone may not remove microscopic disease, and postsurgical adhesions may contribute to postoperative pelvic pain and infertility. As a result, combination therapy, before and/or aer surgery, has been used for several years. e rationale for preoperative medical therapy conducted over a period of 3 to 6 months is to decrease the inammation, the vascularity, and possibly the size of the endometrial implants, thereby allowing easier excision with diminished formation of adhesions. In addition, 6 months of hormonal suppression given preoperatively with all stages of endo­metriosis has demonstrated an improvement in pregnancy rates. Although the optimal length of therapy is still unclear, our current philosophy is to administer a gonadotropin-releasing hormone ago­nist for 3 months prior to denitive surgery. Recent prospective stud­ies have further validated the role of hormone therapy in conjunction with surgical care, demonstrating that those patients had the lowest recurrence and highest cure rate. 

CONCLUSION

Patients with endometriosis involving the intestines, particularly the rectosigmoid junction, commonly report pelvic pain, dyspareu­nia, and rectal bleeding and oen have diculty with fertility. ese symptoms can be related to the depth of penetration and location of the lesion and may be cyclical in nature. Endometriosis can frequently be diagnosed upon physical examination. Imaging studies such as MRI and CT may be ordered to conrm the diagnosis, but frequently they do not adequately illustrate the degree or depth of involvement of these lesions, particularly in the rectosigmoid junction. As a result, the extent of intervention from the colorectal surgeon, be it local excision, segmental excision, or none at all, is commonly decided in the operating room. Augmenting surgical therapy with medical man­agement has been shown to further improve these outcomes, both in reducing recurrence rates and improving fecundity.

S u g g e S t e d R e a d i n g

Alkatout I, Mettler L, Beteta C, etal. Combined surgical and hormone ther-
apy for endometriosis is the most eective treatment: prospective, rand­omized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–481.
Bailey HR, Ott MT, Hartendorp P. Aggressive surgical management for ad-
vanced colorectal endometriosis. Dis Colon Rectum. 1994;37:747–753.
Bazot M, Darai E, Hourani R, etal. Deep pelvic endometriosis: MR imag-
ing for diagnosis and prediction of extension of disease. Radiology. 2004;232:379–389.
Buttram VC, Reiter RC, Ward SM. Treatment of endometriosis with Danazol:
report of a six year prospective study. Fertil Steril. 1985;43:353.
Chapron C, et al. Operative management of deep endometriosis inltrating
the uterosacral ligaments. J Am Assoc Gynecol Laparosc. 1999;6:31–37.
Doniec JM, Kahlke V, Peetz F, etal. Rectal endometriosis: high sensitivity
and specicity of endorectal ultrasound with an impact for the operative management. Dis Colon Rectum. 2003;46:1667–1673.
EndomEtriosis of thE Colon and rECtum344
Doyle JO, Missmer SA, Laufer MR. e eect of combined surgical-medical
intervention on the progression of endometriosis in an adolescent and young adult population. J Pediatr Adolesc Gynecol. 2009;22(4):257–263.
Garcia CR, David SS. Pelvic endometriosis: infertility and pelvic pain. Am J
Obstet Gynecol. 1977;129:740–747.
Hughes EG, Fedorkow DM, Collins JA. A quantitative overview of controlled
trials in endometriosis-associated infertility. Fertil Steril. 1993;59:963–970.
Inoue M, Kobayshi Y, Honda I, et al. e impact of endometriosis on
the reproductive outcome of infertile patients. Am J Obstet Gynecol. 1992;167:278–282.
Jansen RPS. Minimal endometriosis and reduced fecundability: prospective
evidence from an articial insemination by donor program. Fertil Steril. 1986;46:141–143.
Jeong SY, Chung DJ, Myung Yeo D, etal. e usefulness of computed tomo-
graphic colonography for evaluation of deep inltrating endometriosis: comparison with magnetic resonance imaging. J Comput Assist Tomogr. 2013;37(5):809–814.
Jerby BL, etal. Laparoscopic management of colorectal endometriosis. Surg
Endosc. 1999;13:1125–1128.
Koninckx PR, Meuleman C, Demeyere S, etal. Suggestive evidence that pelvic
endometriosis is a progressive disease, whereas deeply inltrating endo­metriosis is associated with pelvic pain. Fertil Steril. 1991;55:759–765.
Manganaro L, Vittori G, Vinci V, etal. Beyond laparoscopy: 3-T magnetic
resonance imaging in the evaluation of posterior cul-de-sac obliteration. Magn Reson Imaging. 2012;30(10):1432–1438.
Olive DL, Lee KL. Analysis of sequential treatment protocols for endometrio-
sis-associated infertility. Am J Obstet Gynecol. 1986;154:613.
Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of
articial insemination in 2193 nulliparous women with azoospermic husbands. CECOS. N Engl J Med. 1982;306(7):404–406.
P C
I
Susan Galandiuk, Jonathan Rice, Peter G. Deveaux, and Russell Farmer


INTRODUCTION

Pneumatosis cystoides intestinalis (PCI) is a condition in which multiple gas-lled cysts occur under the serosa or mucosa of the gastrointestinal tract. PCI is uncommon but increasingly is being recognized and reported. PCI was described by Du Vernoi in 1730 during cadaver dissection, and it has long been noted in animals. PCI occurs in two clinical settings: fulminant, which usually requires immediate surgery, and benign, an incidental nding at colonoscopy or laparotomy. 

ETIOLOGY

PCI has several possible causes, the most notable of which are mechanical and bacterial. e mechanical theory suggests that gas is forced into the bowel wall by one or more mechanisms: (1) pul­monary action, (2) trauma, (3) mucosal injury, (4) anastomoses, (5) obstruction, (6) increased pressure, or (7) increased peristalsis. Chronic obstructive pulmonary disease may be associated with PCI. Because coughing, articial insuation of the lungs, straining, and alveolar ectasia lead to alveolar rupture, air is thought to dissect into the mediastinum, along the great vessels to the retroperitoneum, and along the perivascular space, through the mesentery, to the bowel serosa. Experiments in the early 1960s showed that injection of air into a catheter inserted into the mediastinum of animals resulted in subserosal PCI of the colon and sigmoid. e distribution of PCI is related to the bowel vascular pattern and has been reported aer such procedures as sigmoidoscopy, colonoscopy, and mucosal biopsy. Breaks in mucosal integrity, such as ulcerations, also may permit entry of intraluminal gas into the bowel wall. PCI has been reported aer end-to-end anastomosis and with increased frequency in patients who have undergone a jejunoileal bypass. In these patients, the con­dition aects the bypassed small bowel—usually the midjejunum. Some investigators believe that the ileosigmoid anastomosis permits large bowel ora to enter the ileum, with subsequent increased gas production and cyst formation. Other researchers believe that the absence of bile may increase bacterial growth, leading to increased hydrogen production and cyst formation.
A bacterial origin of PCI is supported by several analyses of cyst gas. Normal luminal gas is approximately 15% hydrogen, compared with 50% hydrogen found in PCI cysts. Common species in the gut microbiome are known hydrogen producers. e bacterial cause of PCI is also supported by breath-hydrogen analyses of aected patients. Many patients with PCI have increased breath hydrogen lev­els, leading some investigators to postulate that the high amount of hydrogen produced by bacteria may be responsible for the persistence of cysts. Several investigators have injected organisms such as Esch- erichia coli, Enterobacter aerogenes, and Clostridium perfringens into intestinal submucosa in animals during experiments and were able to induce PCI. It is thought that a functional break in the mucosa, with
penetration of bacteria into the submucosa or subserosa or both, may be involved in this formation of intestinal gas cysts. Interestingly, the phenomenon of PCI persists independent of the bacteria undergoing translocation. Decreased intestinal mucosal resistance to infection or ulceration also may lead to severe fulminant PCI, which occasionally is seen in adults. 

CLASSIFICATION

PCI is still a relatively uncommon nding. It can be classied as either adult or infantile and can be benign or fulminant. Infantile PCI is usually submucosal and fulminant, as acute necrotizing enterocolitis, with edema of the bowel wall and dilatation of lymphatics. In adults, PCI is usually benign. However, fulminant PCI can occur with a high mortality rate despite surgery. e benign form can be divided into primary (idiopathic) and secondary forms. e cysts are submucosal, subserosal, or both, and are usually found incidentally. e second­ary form of the disease accounts for approximately 85% of cases. PCI aecting the small bowel and ascending colon is thought to be sec­ondary, whereas that aecting the descending colon is idiopathic or primary. Secondary PCI can be associated with a proximal gastro­intestinal lesion such as pyloric stenosis or with chronic obstructive pulmonary disease. Box 69-1 illustrates some conditions associated with secondary PCI. 

HISTOLOGY AND GROSS PATHOLOGY

e histologic changes observed in PCI can be replicated by inject­ing air into subcutaneous tissue. Aer several days a foreign body reaction occurs with inammation, development of a histiocytic lining, and pericyst brosis. e intestinal gas cysts of PCI are also surrounded by foreign body giant cells and macrophages (Fig. 69-1). Serosal cysts usually occur near the mesenteric border, with only a few on the antimesenteric margin. Cysts are frequently located on loops of dilated bowel and range in size from a few millimeters to several centimeters. ey can occur singly or in clusters, occasionally appearing like soap bubbles on the serosa (Fig. 69-2). Submucosal cysts, although not visible, give the bowel a spongy consistency; cyst gas is under pressure and “hisses” when the cysts are punctured. 

SYMPTOMS

Symptoms associated with PCI are nonspecic and may include diar­rhea and distention. Lesions in the terminal ileum or colon may occur in the context of a patient with constipation, rectal bleeding, passage of mucus per rectum, abdominal pain, vague abdominal discomfort, weight loss, malabsorption, and excessive atus. Hemorrhage associ­ated with PCI is presumed to be due to congested mucosa overlying
345
Pneumatosis Cystoides intestinalis346
BOX 69-1: Conditions Associated With Secondary
Pneumatosis Cystoides Intestinalis
Gastrointestinal
Necrotizing enterocolitis Pseudomembranous colitis Ulcerative colitis Crohn disease Diverticulitis Appendicitis Cholelithiasis Volvulus Intestinal obstruction or strangulation Intestinal anastomosis Tuberculous enteritis Refractory celiac sprue Mucosal trauma Idiopathic megacolon Neurogenic bowel dysfunction Esophageal stricture Peptic ulcer disease, including pyloric channel lesion Pyloric stenosis 
Nongastrointestinal
Chronic obstructive pulmonary disease, including emphysema
and asthma Cystic brosis Collagen vascular diseases Systemic sclerosis Dermatomyositis Exposure to alkyl halides, including chloral hydrate and trichlo-
roethylene Steroid therapy Cancer chemotherapy Transplant-related immunosuppression
Kidney
Heart
Liver
Gra-versus-host disease Lactulose treatment Cytomegalovirus infection Acquired immune deciency syndrome Leukemia Lymphoma
From Wong SL, Galandiuk S. Pneumatosis cystoides intestinalis. In: Zuidema GD, Yeo CJ, eds. Surgery of the Alimentary Tract. 5th ed. Vol. 5. Philadelphia: Saunders; 2002: 461-466.
FIGURE 69-1 High-magnification photomicrograph of pneumatosis
cystoides intestinalis illustrating a gas cyst (arrow), lined in part by multinucleated giant cells.
FIGURE 69-2 Benign pneumatosis cystoides intestinalis with subserosal
cysts on the mesenteric margin of the ileum distal to a small bowel stenosis.
the cysts. If partial small bowel obstruction occurs as a result of the cysts, the patient may experience symptoms of vomiting and abdomi­nal distention. Diarrhea and abdominal distention are the most fre­quent presenting symptoms in patients with jejunoileal bypass and PCI. Increased or abnormal peristalsis due to the presence of cysts may lead to volvulus. Spontaneous pneumoperitoneum is seen more frequently with the small bowel variant. Complications that can occur in this condition include volvulus, pneumoperitoneum, intussusception, intestinal obstruction, tension pneumoperitoneum, intestinal perforation, and hemorrhage. Cysts also may lead to extrin­sic compression of the bowel and cause obstructing adhesions. Lack of symptoms is common, although only for the benign form of PCI. Fulminant PCI, as in necrotizing enterocolitis, may cause pneumo­peritoneum, diarrhea, abdominal pain, bleeding per rectum, and ultimately leukocytosis with overt signs of peritonitis and sepsis. 

DIAGNOSIS

In fulminant cases, a plain lm of the abdomen may show gas in the bowel wall and pneumoperitoneum (Fig. 69-3). Crepitance may be a nding on rectal examination. Ischemic or hemorrhagic necrosis of the bowel with mesenteric thrombosis is oen present at the time of the operation or may be seen on preoperative computed tomography (CT) or CT angiography scans. CT scans may show air in the bowel wall or tracking along the mesenteric vessels to the liver (Figs. 69-4 and 69-5). In infantile PCI, concentric rings of gas in the small bowel are pathog­nomonic. Gas-lled cysts may protrude into the lumen, and streaks of air may separate loops of bowel. Gas also may be seen in the portal and mesenteric veins, which is usually a very ominous sign.
e benign forms of PCI may present with free air under the diaphragm or retroperitoneal gas outlining the kidneys, indicating spontaneous perforation with pneumoperitoneum or pneumoretro­peritoneum. PCI can result in prolonged recurring idiopathic and asymptomatic pneumoperitoneum without peritonitis. e small bowel is usually involved in these cases. Persistent pneumoperito­neum implies that gas enters the peritoneum at a rate equal to its absorption. Some investigators have suggested that subserosal cysts rupture, followed by repair of rupture sites and relling of cysts. Repeated rupture occurs, with brosis and obliteration of older cysts. In the absence of pneumoperitoneum, this curious disease of the small bowel cannot be diagnosed on abdominal plain lms. Cysts are dicult to dierentiate from the small bowel gas pattern. PCI of the colon may have a polypoid appearance upon a barium enema and colonoscopy. Cysts can be dierentiated from growths and intramural hematomas, because the entire cyst outline is visible. Unlike polyps, cyst size changes with distention of the colon, with attening of the base, and the radiolucency extends into the bowel wall. In some cases, PCI can be diagnosed by sigmoidoscopy.
COLON 347
FIGURE 69-3 A flat film of the abdomen revealing pneumoperitoneum
and air in the bowel wall (dark arrows in right lower quadrant).
FIGURE 69-4 Computed tomography showing a patient with pneuma-
tosis cystoides intestinalis of the gastric wall (right arrow) and hepatic portal venous gas (left arrow).
Dierential diagnosis is rarely a problem; the condition is usu­ally an incidental nding at laparotomy. Enterogenous intestinal cysts may be confused with PCI. ese cysts are usually single and intramural, most frequently seen in the terminal ileum, lined by intestinal mucosa, and occur in young adults and children. Diuse tissue emphysema is usually secondary to a gas-producing infection and quite dierent from PCI, because gas is distributed in all tissue
FIGURE 69-5 Computed tomography showing a patient with small
bowel pneumatosis cystoides intestinalis (arrow) and air tracking along mesenteric vessels.
spaces. In emphysematous gastritis, gas is present in the stomach wall. Unlike PCI, this condition is characterized by hematemesis, pain, and leukocytosis. Lymphangioma of the peritoneum is an extremely rare entity that may resemble PCI. In lymphangioma of the peritoneum, however, cysts contain lymph rather than gas and are not lined by giant cells. In sclerosing lipogranulomatosis, which usually occurs in fat tissue, cystic spaces are lined by macrophages and giant cells, but these spaces are lled with fat rather than gas. Lymph nodes aected by Whipple disease appear similar to those in pneumatosis but are associated with intestinal lipodystrophy, whereas those in pneumato­sis are not associated with intestinal lipodystrophy. 

TREATMENT

Benign PCI noted as an incidental nding at a laparotomy for another indication may not require any treatment but may warrant an intra­operative consultation. If a segment of bowel aected by subserosal cysts is found during the course of a laparotomy or laparoscopy, an eort should be made to ensure that no obstruction is present and that there is no loss of integrity of the bowel wall itself. If an obstruc­tion is found, it should be treated with resection or strictureplasty (Fig. 69-6). Strictureplasty, for example, is used in the treatment of short brotic strictures in patients with Crohn disease. If nonviable areas of bowel are found, the aected segments must be resected. e most important goal prior to therapy is to recognize the entity for what it is. In some patients, colectomy has been performed for PCI that appeared to be multiple polyps on a barium enema study. In addition, abdominoperineal resections have been performed for lesions that were thought to be malignant but were actually PCI cysts. If the patient has no symptoms and the aected bowel shows no vas­cular compromise, no therapy is indicated.
In the rare cases of symptomatic but benign PCI, several treatment options are available. Recurrence aer treatment is very high. PCI has been successfully treated with high-ow oxygen breathing or hyperbaric oxygen therapy, which is based on the fact that gas cysts are lled mostly
Pneumatosis Cystoides intestinalis348
Benign PCI
Benign PCI identified on imaging study (e.g., pneumoperitoneum on plain film)
Assess patient for risk factors: COPD, history of jejunoileal bypass, immunosuppressive therapy,
collagen vascular diseases, cystic fibrosis, others
Exclude ulcer disease, Crohn disease,
Negative –
no treatment
EGD, colonoscopy
other mucosal disease
Small bowel capsule
Enteroscopy
Hydrogen breath test
Positive–oral neomycin or
metronidazole, 250 mg qid
FIGURE 69-6 Treatment algorithm for benign pneumatosis cystoides intestinalis (PCI). COPD, Chronic
obstructive pulmonary disease; EGD, esophagogastroduodenoscopy; qid, four times a day.
Benign PCI identified as incidental finding
during laparotomy for other indication
Assess affected bowel for obstruction due to
No obstruction Bowel obstruction due to PCI
No treatment of PCI Short fibrotic stricture
PCI
Long segment
Strictureplasty
Resection
with gases other than oxygen at a pressure above atmospheric pressure. Increasing the concentration of inhaled oxygen results in a higher partial pressure of oxygen and a lower partial pressure of nitrogen. Most of the oxygen is metabolized as it passes through tissue and the end capillary gas pressure decreases, resulting in a pressure gradient with diusion of cyst gas into the blood. Several physicians have used inhalation of 70% oxygen via non-rebreather mask or a head tent, resulting in a partial oxy­gen pressure of approximately 250 mm Hg for a few days, which may result in partial or complete radiologic and colonoscopic resolution of PCI and associated symptoms. Only hyperemic and edematous mucosa are visible on follow-up colonoscopy. To lessen pulmonary and central nervous system toxicity, hyperbaric oxygen treatment at 2.5 atm for
2.5 hours for 2 to 3 consecutive days has been recommended. Recur­rence has been reported as early as 1 year later and occasionally may occur immediately. Another therapeutic option for patients with symptomatic benign PCI is a 2-week elemental diet. High fasting hydrogen breath levels decrease aer this diet, and gas production is decreased, because the elemental diet does not reach the colon and less hydrogen is formed by bacteria. Recurrence rates are high aer this form of treatment, and cysts have been reported to occur as early as 4 months aer resuming a regular diet. Another alternative treatment is chronic oral antibiotic therapy with agents such as neomycin or metroni­dazole, but the recurrence rate is also high with this treatment.
In patients with PCI, treatment is determined by the patient’s clin­ical condition. Benign PCI is usually asymptomatic, and no treatment is required. Fulminant PCI seen on CT or a plain abdominal radio­graph with associated pneumoperitoneum, increasing leukocytosis, fever, and a deteriorating clinical course suggests hemorrhagic or ischemic necrosis of the bowel, and the patient’s condition is usually poor. Resection of the involved segment with exteriorization of the ends of the bowel is the safest way to proceed. Failure to operate may lead to bowel necrosis, perforation, sepsis, and death. Depending on the timing of the operation, the mortality rate is very high.

S u g g e S t e d R e a d i n g S

Coriat R, Ropert S, Mir O, et al. Pneumatosis intestinalis associated with
treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors, sorafenib and sunitinib. Invest New Drugs. 2011;29:1090–1093.
DuBose JJ, Lissauer M, Maung AA, etal. Pneumatosis intestinalis: predic-
tive evaluation study (PIPES): a multicenter epidemiologic study of the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2013;75:15–23.
Duron VP, Rutigliano S, Machan JT, etal. Computed tomographic diagnosis
of pneumatosis intestinalis: clinical measures predictive of the need for surgical intervention. Arch Surg. 2011;146:506–510.
Galandiuk S, Fazio VW. Pneumatosis cystoides intestinalis: a review of the
literature. Dis Colon Rectum. 1986;29:358–363.
Kernagis LY, Levine MS, Jacobs JE. Pneumatosis intestinalis in patients with
ischemia: correlation of CT ndings with viability of the bowel. AJR. 2003;180:733–736.
Lee KS, Hwang S, Rua SMH, etal. Distinguishing benign and life-threatening
pneumatosis intestinalis in patients with cancer by CT imaging features. AJR. 2013;200:1042–1047.
Morris MS, Gee AC, Cho SD, etal. Management and outcome of pneumatosis
intestinalis. Am J Surg. 2008;195:679–682.
St. Peter SD, Abbas MA, Kelly KA. e spectrum of pneumatosis intestinalis.
Arch Surg. 2003;138:68–75.
ornton E, Howard SA, Jagannathan J, etal. Imaging features of bowel toxici-
ties in the setting of molecular targeted therapies in cancer patients. Br J Radiol. 2012;85:1420–1426.
Way ne E, Ough M, Wu A, Liao J, etal. Management algorithm for pneuma-
tosis intestinalis and portal venous gas: treatment and outcome of 88 con­secutive cases. J Gastrointest Surg. 2010;14:437–448.
C
Evie Carchman and Massarat Zutshi


INTRODUCTION

Constipation is the most common bowel complaint in the United States, with an estimated prevalence of 2% to 27%. e wide range is attributed to the variety of denitions of constipation used by patients and physicians. e Rome Criteria, which were developed to provide a standardized denition, require two or more of the following con­ditions for at least 3 months: straining more than 25% of the time, hard stools for more than 25% of the time, incomplete evacuation more than 25% of the time, and/or two or fewer bowel movements per week. Using these criteria, the estimated prevalence of constipa­tion is 15%, and half the persons aected have obstructed defecation syndrome. Other standardized denitions exist, such as the one by Cleveland Clinic Florida.
Women are two to three more times likely to have constipation than are men. e National Health and Nutrition Examination Sur­vey reported a 10.2% prevalence of constipation in women and a
4.0% prevalence in men. Constipated patients reported eating fewer fruits and vegetables and drinking more coee or tea. e incidence of constipation increases with age. 

CAUSES

Causes of constipation may be mechanical, functional, or a combi­nation of both. Nonmechanical causes with a normal caliber colon can include reduced peristalsis as a result of immobility, use of drugs, increasing age, metabolic disorders, endocrine disorders, neurologic disease, dietary deciencies, physical or sexual abuse, or just slow transit. When constipation is associated with a dilated colon, causes include Hirschsprung disease, Chagas disease, and Ogilvie syndrome. Anatomic factors aecting defecation include rectal inertia, anismus, and paradoxical internal sphincter contraction. Rectal prolapse, descending perineum syndrome, and rectocele are related ndings.
Sometimes an episode of gastroenteritis will result in continued bowel symptoms long aer the oending bacteria or virus has been eliminated. e cause of constipation in these patients is unknown, but up to 25% of cases of irritable bowel syndrome (IBS) may be due to this problem. Chronic treatment with opioids is a specic and common cause of colonic inertia due to activation of central μ-opioid receptors in the gastrointestinal tract. Opioid-induced constipation is associated with increased use of health care dollars and decreased quality of life. Laxatives alone are usually insucient to treat this con­dition because they do not target the underlying cause of the consti­pation (μ-opioid receptor activation). Methylnaltrexone bromide is a peripherally acting μ-opioid receptor antagonist, and data support its use for opioid-induced constipation with a favorable tolerance pro­le. Rare cases of chronic pseudo-obstruction, an unusual disorder of the gastrointestinal tract characterized by impaired peristalsis that can lead to constipation or diarrhea, also have been reported. Patients present with symptoms of bowel obstruction, but no mechanical
cause is identied. Subgroups of this rare disorder include neurop­athy, myopathy, or mesenchymopathy, with neuropathy the most prevalent. Forty percent of cases are primary and 60% are secondary. is disease is normally progressive. Treatment includes ruling out obstruction, evaluating for myopathy or neuropathy, and providing nutritional support. 

CLASSIFYING CONSTIPATION

Clinically, patients with constipation are classied into several categories:
1. Slow transit (colonic inertia)
2. Irritable bowel syndrome—constipation predominant (IBS-C)
3. Pelvic oor dysfunction (obstructed defecation syndrome)
4. Mixed slow transit/pelvic oor disorder
Colonic inertia is frequently associated with symptoms since childhood and laxative dependency. IBS-C is usually accompanied by abdominal pain (which is oen relieved by defecation) and irregular bowel habits. Pelvic oor dysfunction or obstructed defecation syn­drome refers to a symptom complex of prolonged straining, the sensa­tion of incomplete evacuation, and the need for digital manipulation. 

ASSESSMENT

History
History is the key to the diagnosis of constipation, and taking time to develop a full picture of the patient’s symptoms in the setting of his or her overall health and lifestyle is worthwhile. Obtaining a detailed account of what constipation means to each individual patient is very important. Information should be obtained about stool frequency, consistency, size, and the presence of urgency/straining/incomplete evacuation. e Bristol Stool Form Scale (BSFS) can provide a visual and numeric reference as a rough estimate of colonic transit. Lower scale numbers on the BSFS mean slower transit. e BSFS is scored between 1 and 7 as follows:
1. Small hard lumps, like nuts
2. Sausagelike but lumpy
3. Sausagelike or snakelike with a cracked surface
4. Sausagelike or snakelike, smooth and so
5. So blobs with clear-cut edges
6. Fluy pieces with ragged edges (a mushy stool)
7. Watery stool
e age at which symptoms began should be documented. Con­stipation from infancy raises the possibility of Hirschsprung disease. One should ask about typical dietary choices, focusing on ber content
349
Constipation350
and supplementation, and review the eect of ber supplementation on constipation. Some but not all patients nd ber supplementation helpful. e patient should be asked about other symptoms such as abdominal pain/discomfort/bloating and the eect of defecation on these symptoms, which may be suggestive of other disease or IBS­C. e following histories should be obtained and critically assessed: detailed medical (including diabetes, hypothyroidism, hypercal­cemia, connective tissue disorder, and neurologic disease), family, dietary, psychiatric, surgical, obstetric, and drug (including opiates, iron, antiparkinsonian drugs, anticholinergic drugs, calcium channel blockers, and antidepressants). Urinary symptoms and sexual dys­function may be important because multicompartment pelvic oor disease is common. A history of sexual/physical abuse, eating disor­ders, or psychiatric illnesses may be an important factor in the onset and chronicity of the constipation.
Several validated constipation questionnaires dierentiate con­stipated patients from healthy volunteers. e constipation severity instrument is one example. It provides a short, self-reported assess­ment of constipation severity and identies subtypes of constipation. e total scale ranges from 0 to 73, with higher scores associated with more severe symptoms. 
Physical Examination
A thorough physical examination includes a generalized assessment, with particular emphasis on abdominal, neurologic, anorectal, peri­neal, and vaginal examinations. Some important points of anal and pelvic examinations are as follows:
n On anorectal examination, the status of the rectum should be
noted—capacious, empty, or full of stool. e sphincter muscle tone is documented. A patulous anus may indicate neurologic injury or injury as a consequence of mechanical factors, such as long-standing rectal prolapse. An unusually tight anus (an­ismus) may be a cause of incomplete defecation and anal pain. Sphincter coordination is examined when patients are asked to squeeze, relax, and then push. With paradoxical puborectalis contraction, the pelvic oor muscle contracts instead of relax­ing when the patient strains down or attempts to defecate.
n Rectal prolapse can cause constipation but also fecal inconti-
nence. When rectal prolapse is suspected but not seen on ex­amination, the patient should be asked to bear down or sit on the toilet to simulate defecation.
n A rectocele is dened as a herniation of the anterior rectal wall
into the vagina. Rectocele severity can be expressed as stages I to IV and depends on the maximal protrusion inferiorly with reference to the hymeneal ring. A rectocele sometimes develops secondarily to obstructed defecation, and pelvic oor assess­ment for paradox is important. A large rectocele sometimes can be seen just by inspecting the perineum, with the anterior wall of the rectum protruding through the posterior wall of the va­gina. One can see a size increase when the patient bears down.
n Rectoanal intussusception, also called internal intussuscep-
tion, internal prolapse of the rectum, and occult rectal pro­lapse, is a funnel-shaped infolding of the rectum that can oc­cur with Valsalva maneuvers. It is thought to be the start of rectal prolapse. Descent of the perineum beyond the level of the ischial tuberosities is suggestive of perineal descent.
n Anoscopy can identify mucosal abnormalities and rectoanal
intussusception. When the patient is asked to bear down as the anoscope is removed, the redundant rectal mucosa can be seen impacting into the anus.
n Gynecologic examination focuses on an examination of the
posterior vaginal wall. Prolapse should be noted and staged based on the Pelvic Organ Prolapse Quantication System. e physical examination for patients with IBS-C and motility disorders is frequently normal. 

INVESTIGATIONS

With regard to blood work, an evaluation for electrolyte abnormali­ties (calcium), diabetes, and thyroid function tests is basic, especially if obstructed defecation has been ruled out.
A colonoscopy should always be performed to exclude mechani­cal causes of obstruction such as a stricture, cancer, or diverticular disease. Sigmoid colon adhesions aer pelvic surgery in women can produce signicant obstruction, with symptoms that are oen mis­diagnosed as IBS. During colonoscopy, insertion through the sig­moid is dicult and reproduces the pain and bloating with which the patient has presented. A sigmoid colectomy should be considered.
Anal manometry provides information on resting and squeeze anal sphincter pressures, the presence of rectoanal inhibitory reex (RAIR), rectal sensation, rectal compliance, and balloon expulsion. Assessment of rectal sensation is performed by determining the low­est volume that evokes a sensation of rectal lling and the maximum tolerable volume. is assessment is important in patients with fecal incontinence but also in patients with rectal hyposensitivity. Con­stipated patients may demonstrate internal sphincter hypertonia. e presence of a RAIR excludes Hirschsprung disease (although its absence is not proof of Hirschsprung disease; other conditions, such as megarectum, can account for the absence of a RAIR). Balloon expulsion assesses the ability to evacuate and can reliably diagnose pelvic oor outlet obstruction (i.e., the inability to expel a 50- to 100­mL balloon in less than 1 minute).
Electromyography aids in the diagnosis of paradoxical or non­relaxing puborectalis muscle by demonstrating activation of the puborectalis during defecation.
Transit marker studies or nuclear medicine transit studies identify colonic dysmotility. With the sitz marker test, the patient ingests one or two capsules containing 24 small plastic markers each (rings and panels). Transit time is estimated based on the rate at which these markers are eliminated. We instruct patients to take one capsule early Sunday morn­ing. e patient then undergoes serial abdominal radiographs, with one on Monday morning, the next on Wednesday, and the nal on Friday. Dierent institutions use dierent practices, therefore the radiologist should verify and report how many and when the capsules were taken. Patients are told to eat two servings of over-the-counter high-ber prod­ucts daily in addition to their usual diet (30 g ber total) and not to use laxatives. Colonic transit is normal if 80% (38 of 48) of the rings have been eliminated by day 5. e distribution of the markers throughout the colon is also important. If the markers tend to accumulate in the rectum, then outlet obstruction is likely. If the markers remain scattered through­out the colon and more than 20% of the markers remain on the h day, then colonic inertia is the diagnosis (Fig. 70-1).
Scintigraphic evaluation is not as widely available but is useful in terms of assessing transit of the proximal small bowel in addition to the colon. Scintigraphic evaluation utilizes a radiolabeled meal as the marker of transit. Small bowel and gastric emptying can be determined and is useful in patients who have received a diagnosis of slow-transit constipation, because patients with generalized motility disorders have less favorable results aer surgical intervention.
Video defecography demonstrates the mechanism of defecation, providing information on the anatomic relationships of the anus, rectum, sigmoid, vagina, and pelvic oor during defecation. ick­ened barium paste is introduced into the rectum until the patient experiences the urge to defecate. e vagina is then opacied with Gastrogran. Pictures are taken at rest and at maximal squeeze prior to starting video recording. Patients are asked to squeeze, relax, and defecate. At the end of the study, three reference lines are drawn— anorectal angle, puborectalis length, and extent of perineal descent. A study with normal ndings will demonstrate relaxation of the puborectalis during defecation (an increase in the anorectal angle, lengthening of puborectalis, and blunting of the puborectalis notch). Defecography can also identify intussusception, rectal prolapse, enterocele, sigmoidocele, rectocele, and perineal descent (Fig. 70-2,
A and B).